Literature DB >> 26139107

Adverse effects of conventional thrice-weekly hemodialysis: is it time to avoid 3-day interdialytic intervals?

Panagiotis I Georgianos1, Pantelis A Sarafidis, Arjun D Sinha, Rajiv Agarwal.   

Abstract

BACKGROUND: Maintenance hemodialysis is typically scheduled thrice weekly due to simple logistic reasons; thus, the vast majority of hemodialysis patients receive renal replacement therapy for two shorter 2-day intervals and a longer 3-day interval. As compared to the 2-day interval, we review the ill effects of the longer 3-day interdialytic interval in this report.
SUMMARY: Large-scale observational studies show that both cardiovascular-related hospital admissions and mortality occur more frequently on the day following the long interdialytic interval than on any other day of the week. Although the reasons for excess mortality are obscure, several pathophysiologic mechanisms may be involved, such as a greater magnitude of change during the long interdialytic interval in the following parameters: volume status, electrolyte and acid-base status, arterial wall and left ventricle mechanics. These data raise the need for re-examining the issue of timing and frequency of prescribed dialysis regimens in an attempt to improve patient outcomes. Although enhanced-frequency and/or extended-time dialysis schedules may mitigate the risks of the long interdialytic interval, the benefit of such dialytic modalities on survival is not yet proven. Key Message: This article summarizes currently available epidemiologic and pathophysiologic evidence on the adverse effects related to the long interdialytic interval of thrice-weekly hemodialysis and discusses the need to research further alternative dialysis practices that could mitigate these risks.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26139107     DOI: 10.1159/000435842

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  13 in total

Review 1.  Hypertension in Pediatric Dialysis Patients: Etiology, Evaluation, and Management.

Authors:  Raj Munshi; Joseph T Flynn
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

Review 2.  The Ebb and Flow of Echocardiographic Cardiac Function Parameters in Relationship to Hemodialysis Treatment in Patients with ESRD.

Authors:  Charalampos Loutradis; Pantelis A Sarafidis; Christodoulos E Papadopoulos; Aikaterini Papagianni; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2018-03-28       Impact factor: 10.121

Review 3.  Cycles, Arrows and Turbulence: Time Patterns in Renal Disease, a Path from Epidemiology to Personalized Medicine?

Authors:  Jeroen P Kooman; Len A Usvyat; Marijke J E Dekker; Dugan W Maddux; Jochen G Raimann; Frank M van der Sande; Xiaoling Ye; Yuedong Wang; Peter Kotanko
Journal:  Blood Purif       Date:  2018-11-16       Impact factor: 2.614

Review 4.  Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

Review 5.  Blood pressure control in conventional hemodialysis.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Semin Dial       Date:  2018-08-06       Impact factor: 3.455

6.  Mineralocorticoid Receptor Antagonism for Cardiovascular Protection in End-Stage Renal Disease: New Data But the Controversy Continues.

Authors:  Panagiotis I Georgianos; Pantelis A Sarafidis; Vassilios Liakopoulos; Elias V Balaskas; Pantelis E Zebekakis
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-10-12       Impact factor: 3.738

7.  Hemodialysis interval and its association with emergency care and mortality: A nationwide population-based cohort study.

Authors:  Ching-Wen Chien; Chi-Jung Huang; Zi-Hao Chao; Song-Kong Huang; Pei-En Chen; Tao-Hsin Tung
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

8.  Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis.

Authors:  Evangelos Memmos; Pantelis Sarafidis; Panagiotis Pateinakis; Apostolos Tsiantoulas; Danai Faitatzidou; Panagiotis Giamalis; Vassileios Vasilikos; Aikaterini Papagianni
Journal:  BMC Nephrol       Date:  2019-06-11       Impact factor: 2.388

9.  Metabolic and volume status evaluation of hemodialysis patients with and without residual renal function in the long interdialytic interval.

Authors:  Lenina Ludimila Sampaio de Almeida; Luís Henrique Bezerra Cavalanti Sette; Fernando Luiz Affonso Fonseca; Leila Silveira Vieira da Silva Bezerra; Francisco Hélio Oliveira Júnior; Ronaldo Roberto Bérgamo
Journal:  J Bras Nefrol       Date:  2019 Oct-Dec

Review 10.  Multitargeted interventions to reduce dialysis-induced systemic stress.

Authors:  Bernard Canaud; Melanie P Stephens; Milind Nikam; Michael Etter; Allan Collins
Journal:  Clin Kidney J       Date:  2021-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.